Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should the U.S. Export Crude Oil?: Enbridge Inc (USA) (ENB) and More

Page 1 of 2

It’s now common knowledge that the U.S. is in the midst of a massive oil boom, fueled by growing production from shale plays in Texas and North Dakota. The surge in domestic production, coupled with a lack of sufficient pipeline infrastructure, has led to a massive oversupply of oil in the middle of the country.

With more oil than refiners know what to do with, a growing number of experts are suggesting that the surplus oil be exported abroad. Recently, the head of the International Energy Agency, even suggested that not allowing crude exports threatens to bring the American oil boom to a screeching halt. Let’s take a closer look.

Enbridge Inc (USA) (NYSE:ENB)

America’s oil boom
In just the past two years, domestic crude production has risen by 1.3 million barrels per day, with the EIA projecting a further increase of 1.4 million barrels per day by year-end 2014. Extracting all this oil hasn’t been a problem. But transporting the stuff has posed numerous challenges.

Major bottlenecks in transportation, caused by a lack of sufficient pipeline infrastructure, have kept the price of domestic oil far below international prices. In fact, this price differential, as reflected by the Brent-WTI spread, rose to above $20 per barrel last week. And certain grades of inland crude are fetching lower prices still.

Transport difficulties and the Gulf Coast oil mismatch
While midstream companies are working hard to alleviate the oversupply of crude and transport growing volumes to refineries along the Gulf Coast, it remains to be seen whether it will be enough. For instance, an expansion of the Seaway pipeline, which is operated as a 50/50 joint venture between Enterprise Products Partners L.P. (NYSE:EPD) and Enbridge Inc (USA) (NYSE:ENB), is expected to gradually alleviate the oversupply at Cushing — the nation’s biggest oil storage hub — by the end of this year.

And Kinder Morgan Energy Partners LP (NYSE:KMP)‘s Crude Condensate pipeline, or KMCC, which went into service in June, serves growing production from the Texas Eagle Ford shale, which it transports to Phillips 66 (NYSE:PSX)’s refinery in Sweeny, Texas.

But even with this infrastructure buildout, the problem is that many facilities along the U.S. Gulf Coast refining hub are poorly suited to process the light, sweet crude flowing from shale plays in Texas and North Dakota. So if local refiners can’t process it and it’s too costly to be transported to East Coast refineries that are better equipped to process it, it might just make better economic sense to export it.

Recently, Maria van der Hoeven, the head of the International Energy Agency — a 28-member international agency formed in response to the oil crisis of 1973 — made this argument.

The IEA and the EIA in favor of crude exports
She warns that the U.S. government’s archaic stance on exporting crude oil is a major threat to the economic viability of the current American oil boom. Energy companies are motivated to drill for domestic oil as long as its price is sufficiently above its marginal cost of production.

But if the massive discount between domestic oil and Brent persists for much longer, van Der Hoeven argues that “it could threaten the economic viability of these new supplies, potentially stopping the boom in its tracks.” She argues that U.S. crude export restrictions need to be lifted, since U.S. refiners are limited in the quantity of domestic supplies they can handle.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!